Tatva Chintan IPO Live Subscription Status

Live subscription status across each investor category and analyst recommendations
Tatva Chintan IPO Subscription

Tatva Chintan IPO Subscription Status: FINAL

Tatva Chintan Pharma Chem Limited, incorporated in 1996, is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure-directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for supercapacitor batteries, and pharmaceutical and agrochemical intermediates and other specialty chemicals (“PASC”).

Investor CategoryQuotaSubscription
Institutional (QIB)50%185.23x
Non-Insti. (HNI)15%512.22x
Retail (RII)35%35.32x
Total Subscription100%180.34x

Tatva Chintan IPO Subscription: End of Day Update

DayDay 1Day 2Day 3

Tatva Chintan IPO Subscription: Analyst Recommendations

To be Updated…

Tatva Chintan IPO Subscription: Key IPO Details

Issue Size₹500 Cr
Open Date16/07/2021
Close Date20/07/2021
Face Value₹1/- per Equity Share
IPO Price₹1073 – ₹1083
Lot Size13 shares
LotsMin 1 – Max 13

Tatva Chintan IPO : Financials

Revenue from Ops₹206.31 Cr₹2,63.24 Cr₹300.36 Cr
Profit before Excep*₹26.64 Cr₹47.60 Cr₹60.70 Cr
Profit after Tax20.54 Cr₹37.79 Cr₹52.26 Cr
EPS (Basic)10.2318.8126.02
*Tax and Exceptional Items
As of March 2020EPS (Avg)P/E (Floor)P/E (Cap)
Based on basic EPS20.9951.1251.60

Comparison with listed industry peers

As of March 2020P/E
Tatva Chintan Pharma51.60
Industry Average51.60

Tatva Chintan IPO Subscription – FAQs

1. How to apply for Tatva Chintan IPO in the Retail Category?

A: An investor in the retail category may either apply through the UPI process via DEMAT account or the ASBA process via bank account

2. How to apply for Tatva Chintan in HNI Category?

A: An investor can apply in the HNI category only through the ASBA process via bank account

3. Where can I find the Red Herring Prospectus (RHP) details?

A: You can visit the NSE or SEBI website for these details. Alternately you can click here: RHP

Leave a Reply

17 − 15 =

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.